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ABSTRACT
The Peutz-Jeghers syndrome (PJS) is an autosomal dominant
hamartomatous poliposis describred in 1921. Hemminki in 1997
described the presence of LKB-1 mutation tumor-suppressor gen.
The patients with PJS develop a higher cumulative incidence
of gastrointestinal, pancreas and extraintestinal tumors, being oc-
casion of a renew interest on hamartomatous polyposis syndro-
mes regarding the clinical care, cancer surveillance treatment and
long term follow-up.
We report the case of a 38 years old male, diagnosed of PJS
who developed a multiple adenocarcinoma in duodenum and ye-
yunum. Surgically treated and with a long-term free disease survi-
val of 11 years represents the sixth case reported in the spanish li-
terature of PJS associated with a gastrointestinal tumor.
A critical review, molecular alterations and the established cri-
teria of tumor screening and surveillance are reviewed.
Key words: Peutz-Jeghers syndrome. Hamartomatous. Carcino-
genesis. Intestinal polyposis. Hereditary cancer.
INTRODUCTION
Peutz-Jeghers syndrome (PJS) is an autosomal domi-
nant disease characterized by the presence of multiple ha-
martomatous polyps throughout the entire gastrointesti-
nal tract and mucocutaneous melanin pigmentation (1-6).
Hemminki, in 1997, described a deletion in the short
arm of chromosome 19, a mutation in the LKB-1 gene
(also known as STK11) (7-10). In this syndrome a high
cumulative incidence of tumors in the gastrointestinal
tract and other locations (breast, lung, gynecologic) has
been reported. A renewed interest in its molecular patho-
genesis and in the surveillance and screening strategy has
been observed (1,4-6).
CASE REPORT
A 38-year-old male with a previous diagnosis of PJS
was hospitalized in another center for nausea, vomiting,
and abdominal pain. Upper endoscopy revealed a com-
plete obstruction of the duodenal lumen by an extrinsic
mass, which prompted referral to our center.
An abdominal computed tomography (CT) scan (Fig.
1) revealed a solid mass with hypodense areas and infil-
trating appearance compromising the duodenal lumen,
and a jejuno-jejunal intussusception was described. Gas-
troscopy confirmed the presence of multiple gastric
polyps and complete duodenal obstruction. Citology re-
vealed malignant cells.
The patient underwent pancreticoduodenectomy with
a simultaneous resection of 23 cm of jejunum with signs
of intussusception. The patient required no blood transfu-
sion and had an uneventful postoperative course except
for an episode of self-limited hematochezia.
The histopathological examination revealed what fo-
llows: “The main tumor measured 6 cm in diameter and
was located in the duodenum. This tumor obstructed the
duodenum, infiltrated the pancreas, and showed large
cystic areas between 5 and 9 mm in diameter (Fig. 2).
The duodenal tumor showed an atypical epithelial glan-
dular growth pattern, which infiltrated the wall of the
small bowel and pancreas (Fig. 3). Two other similar in-
filtrating tumors, which measured between 1.5 and 5 cm
in diameter, and occupied the entire intestinal wall, were
located in the jejunum. The atypical glands were fre-
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quently cystic and showed characteristics similar to those
in the duodenum. No metastatic tumor was identified in
the periportal or peripancreatic lymph nodes. Primary
well-differentiated multifocal adenocarcinomas origina-
ting from pre-existing polyps were diagnosed.
Multiple polyps in the stomach and jejunum were ob-
served. Gastric polyps were numerous and measured be-
tween 1 and 4 mm in diameter. Three pediculated jejunal
polyps, which measured up to 3 cm in diameter, were ob-
served. Histologically, these tumors showed either hyper-
plastic or adenomatous characteristics. The glands were
cystic and covered with moderately to severely dysplastic
mucosecretory epithelium. Frequent bundles of smooth
muscle from the muscularis mucosae were spread among
the atypical glands”.
A PJS diagnosis had been first established in 1989
when the patient was 29 years old. The patient required
and urgent intestinal resection for an intestinal intussus-
ception and subsequent bowel obstruction. Several ha-
martomatous polyps and phenotypical features – muco-
cutaneous melanosis – were assessed. There was no
family history of “intestinal problems”.
The patient has been followed up for 11 years and re-
mains asymptomatic and recurrence-free. A surveillance
program was implemented with gastroscopies, double-
balloon enteroscopies, two capsule endoscopy studies,
and seven colonoscopies. Fifteen gastric hyperplastic
polyps and 11 hamartomatous polyps, 9 jejunal hamarto-
matous polyps without epithelial dysplasia, 7 colon ha-
martomatous polyps, and 3 adenomatous polyps with
Fig. 1. Axial abdominal CT showing a tumor in the head of the pancreas that obstructs the duodenal lumen.
Fig. 2. Macroscopic view of the duodenum-obstructing tumor. Fig. 3. Microscopic appearance of the tumor showing infiltrating cells
into the pancreas.
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low-grade dysplasia foci were removed without compli-
cations.
DISCUSSION
Peutz-Jeghers syndrome (PJS) was first described by
Peutz en 1921, and then by Jeghers in 1949 (11,12). In
1954 Bruwer “coined” the eponym “Peutz-Jeghers” (13).
PJS is characterized by the presence of multiple adeno-
matous and hamartomatous polyps along the gastrointes-
tinal tract in association with melanocytic pigmentation
around the mouth, but also in the hands and feet and axi-
llary pits. An incidence of 1/8,300 to 1/200,000 live
births has been estimated, and the condition is an autoso-
mal dominant disease that affects both males and fema-
les, and is found in all racial groups.
Three series reviewed 404 PJS patients and reported
jejunal polyps in 78%, colon polyps in 42%, gastric
polyps in 38%, and rectal polyps in 28% of patients (1-
3,6). Epithelial dysplasia foci and invasive carcinoma
have been reported in 26% of polyps (9).
Hemminki was first to describe a deletion in the short
arm of a chromosome 19 region, which was later identi-
fied as a mutation in the LKB-1 gene (19p 13.3), also
known as STK11 (serine/threonine-protein/kinase 11).
LKB-1 acts as a tumor suppressor gene and is believed to
regulate cell orientation, polarization and apoptosis. A
loss of LKB-1 function leads to hamartomatosus polyp
formation and tumor formation because of epithelial po-
larity disruption. This molecular alteration has been re-
ported in 30 to 82% of PJS patients (8-10,14-20).
In addition to the clinical diagnosis and polyp-related
complications such as intestinal obstruction (14%), abdo-
minal pain (23%), rectal bleeding (14%), and polyp intus-
susception (40%) (1-3,6,10), the most challenging clinical
aspect is early tumor or preinvasive lesion identification.
Germ-line mutations are present in 70% of families
with complete penetrance. The cumulative risk of develo-
ping cancer is 93% at 65 years of age, with a median age
at presentation of 43 years. There have been no differen-
ces in cancer incidence between patients with and wit-
hout molecular mutations.
The reported case shows a strong correlation with the
natural course of the disease. The patient was diagnosed
at 29 years of age on presenting with an acute abdominal
complication (1-3,6,10,21,22) and developed multiple
gastrointestinal cancer at 38 years. It represents the sixth
case of intestinal adenocarcinoma in PJS in the Spanish
literature, with previous cases being gastrointestinal ade-
nocarcinomas (stomach, jejunum, jejunum-ileum, and
colon) and one case of simultaneous renal, rectal and
cholangiocarcinoma (23-27).
Dozois et al reported in 1969 eleven cases of gastroin-
testinal cancer out of 321 PJS patients (4 in the stomach,
3 the in duodenum, 1 in the ileum, and 3 in the colon and
rectum) (28).
In 2000 Gianderlo conducted a meta-analysis in order
to define cancer risk in a PJS population, and studied 210
patients from 6 case-series published in Holland and the
UK. The relative risk of cancer was 15.2 with no gender-
specific differences. Age at presentation was 42.9 ± 10.2
years, similar to our reported case (38 years). The cumu-
lative risk of cancer was 93% at 65 years. The highest cu-
mulative incidence was: breast (54%), colon (39%), pan-
creas (36%), stomach (29%), and ovary (21%) (29).
In a later report of 419 PJS patients the cumulative risk
of cancer at age 70 was 85%, four times superior to the
general population. Again colo-rectal and breast tumors
were most frequent (30). The relative risk of gastric and
small-bowel cancer was 84; 213 and 520, respectively,
when compared to the general population (95% CI) (29).
In Gianderlo’s study, six patients developed pancreatic
cancer; age at diagnosis was 41 years with a relative risk
of 36% for this tumor, which supports the need for sur-
veillance to facilitate early detection for pancreatic can-
cer (31-33).
Hearle reported 11 cases of pancreatic cancer in 4,109
individuals with PJS syndrome, but did not report the
outcomes of these cases (30).
Today the existence of precursor lesions giving rise to
invasive pancreatic cancer is well established, with a pat-
tern similar to the adenoma-carcinoma sequence pre-
viously described for colon cancer (34-36). This offers an
opportunity to detect local precursor lesions such as pan-
creatic intraepithelial neoplasia (Pan IN) or early invasi-
ve lesions (< 3 cm), which are amenable to curative re-
section. Screening for invasive pancreatic cancer and its
precursors is currently recommended with endoscopic ul-
trasonography (EUS) and computed tomography (CT)
annually, followed by endoscopic retrograde cholangio-
pancreatography (ERCP) and fine-needle aspiration for
suspect lesions (37).
In the Johns Hopkins experience seven patients out of
38 PJS patients underwent pancreatoduodenectomy. One
of them had an adenocarcinoma of 2.8 cm, and remains
Table I. Case series of malignant tumors in Peutz-Jeghers
syndrome
Author (ref.) Year Patients GI(*) Non-GI
cancer cancer
Utsunomiya (42) 1975 102 12 5
Linos (43) 1981 27 1 3
Giardiello (44) 1987 31 4 11
Spigelman (45) 1989 72 10 7
Boardman (46) 1998 34 10 16
Choi (47) 2000 30 4 1
Lim (48) 2004 240 19 35
Hearle (30) 2006 419 40 26
Mehenni (5) 2007 170 17 10
Total 1,125 107 114
*GI: gastrointestinal.
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free of disease five years after surgery. The other six had
pain with various grades (38).
PJS patients must be included in specific follow-up
programs with screening for pancreas cancer (39-41).
Table I depicts the most numerous series and the inci-
dence of cancer in PJS patients, and table II shows
screening techniques and surveillance strategies (49-54).
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Table II. Surveillance recommendations by age and sex*
Age (years) For males For females
From birth to 12 History/physical exam. Testicle History/physical exam
exploration (ultrasounds every
2 years through year 12)
At age 8 Upper endoscopy. Upper and Upper endoscopy. Upper
small bowel follow-through and small bowel follow-through
series (if positive, every series (if positive, again every
2-3 years) 2-3 years)
At age 10 Capsule endoscopy every Capsule endoscopy every 2-3 years
2-3 years
From age 18 on Colonoscopy, upper endoscopy Colonoscopy, upper endoscopy every
every 2-3 years 2-3 years. Breast self-examination
monthly
From age 21 on Endoscopic ultrasounds every Pelvic exam, transvaginal ultrasounds
2 years (abdominal CT and and serum CA-125 annually.
CA-19.9 optional) Mammography annually (abdominal
CT every 2 years and CA-19.9 is
optional)
*Adapted from Giardello (39).
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